Literature DB >> 22804476

Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent.

Matteo Riva1, Eva Källberg, Per Björk, Dora Hancz, Thomas Vogl, Johannes Roth, Fredrik Ivars, Tomas Leanderson.   

Abstract

Interactions between danger-associated molecular patterns (DAMP) and pathogen-associated molecular patterns (PAMP) and pattern recognition receptors such as Toll-like receptors (TLRs) are critical for the regulation of the inflammatory process via activation of nuclear factor-κB (NF-κB) and cytokine secretion. In this report, we investigated the capacity of lipopolysaccharide (LPS) -free S100A9 (DAMP) protein to activate human and mouse cells compared with lipoprotein-free LPS (PAMP). First, we showed that LPS and S100A9 were able to increase NF-κB activity followed by increased cytokine and nitric oxide (NO) secretion both in human THP-1 cells and in mouse bone marrow-derived dendritic cells. Surprisingly, although S100A9 triggered a weaker cytokine response than LPS, we found that S100A9 more potently induced IκBα degradation and hence NF-κB activation. Both the S100A9-induced response and the LPS-induced response were completely absent in TLR4 knockout mice, whereas it was only slightly affected in RAGE knockout mice. Also, we showed that LPS and S100A9 NF-κB induction were strongly reduced in the presence of specific inhibitors of TLR-signalling. Chloroquine reduced S100A9 but not LPS signalling, indicating that S100A9 may need to be internalized to be fully active as a TLR4 inducer. This was confirmed using A488-labelled S100A9 that was internalized in THP-1 cells, showing a raise in fluorescence after 30 min at 37°. Chloroquine treatment significantly reduced the fluorescence. In summary, our data indicate that both human and mouse S100A9 are TLR4 agonists. Importantly, S100A9 induced stronger NF-κB activation albeit weaker cytokine secretion than LPS, suggesting that S100A9 and LPS activated NF-κB in a qualitatively distinct manner.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22804476      PMCID: PMC3461398          DOI: 10.1111/j.1365-2567.2012.03619.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

2.  Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells.

Authors:  J Edgeworth; M Gorman; R Bennett; P Freemont; N Hogg
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 3.  Alarmins: chemotactic activators of immune responses.

Authors:  Joost J Oppenheim; De Yang
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

Review 4.  Proteasome inhibitors: valuable new tools for cell biologists.

Authors:  D H Lee; A L Goldberg
Journal:  Trends Cell Biol       Date:  1998-10       Impact factor: 20.808

Review 5.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  Chloroquine inhibits proinflammatory cytokine release into human whole blood.

Authors:  I Karres; J P Kremer; I Dietl; U Steckholzer; M Jochum; W Ertel
Journal:  Am J Physiol       Date:  1998-04

7.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues.

Authors:  G Zwadlo; J Brüggen; G Gerhards; R Schlegel; C Sorg
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1.

Authors:  A Cuenda; J Rouse; Y N Doza; R Meier; P Cohen; T F Gallagher; P R Young; J C Lee
Journal:  FEBS Lett       Date:  1995-05-08       Impact factor: 4.124

9.  Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.

Authors:  K Inaba; M Inaba; M Deguchi; K Hagi; R Yasumizu; S Ikehara; S Muramatsu; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.

Authors:  D R Alessi; A Cuenda; P Cohen; D T Dudley; A R Saltiel
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

View more
  53 in total

1.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 2.  Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes.

Authors:  John K Hermann; Jeffrey R Capadona
Journal:  Crit Rev Biomed Eng       Date:  2018

3.  S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.

Authors:  Nikolaos G Frangogiannis
Journal:  Eur Heart J       Date:  2019-08-21       Impact factor: 29.983

4.  Signaling between pancreatic β cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation.

Authors:  Hideaki Inoue; Jun Shirakawa; Yu Togashi; Kazuki Tajima; Tomoko Okuyama; Mayu Kyohara; Yui Tanaka; Kazuki Orime; Yoshifumi Saisho; Taketo Yamada; Kimitaka Shibue; Rohit N Kulkarni; Yasuo Terauchi
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

5.  Avian MRP126 Restricts Microbial Growth through Ca(II)-Dependent Zn(II) Sequestration.

Authors:  Aaron T Bozzi; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2020-01-21       Impact factor: 3.162

6.  S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways.

Authors:  Jin Hyun Kang; Sae Mi Hwang; Il Yup Chung
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

7.  Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration.

Authors:  Congcong Zhang; Yulin Li; Yina Wu; Luya Wang; Xiaonan Wang; Jie Du
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

8.  S100A9 induces nucleus pulposus cell degeneration through activation of the NF-κB signaling pathway.

Authors:  Song Guo; Qihang Su; Junxiang Wen; Kai Zhu; Jun Tan; Qiang Fu; Guixin Sun
Journal:  J Cell Mol Med       Date:  2021-03-18       Impact factor: 5.310

9.  Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.

Authors:  Yi-Hao Chan; Siew-Wai Fong; Chek-Meng Poh; Guillaume Carissimo; Nicholas Kim-Wah Yeo; Siti Naqiah Amrun; Yun Shan Goh; Jackwee Lim; Weili Xu; Rhonda Sin-Ling Chee; Anthony Torres-Ruesta; Cheryl Yi-Pin Lee; Matthew Zirui Tay; Zi Wei Chang; Wen-Hsin Lee; Bei Wang; Seow-Yen Tan; Shirin Kalimuddin; Barnaby Edward Young; Yee-Sin Leo; Cheng-I Wang; Bernett Lee; Olaf Rötzschke; David Chien Lye; Laurent Renia; Lisa F P Ng
Journal:  EMBO Mol Med       Date:  2021-05-27       Impact factor: 12.137

10.  S100A9 Derived From Myeloma Associated Myeloid Cells Promotes TNFSF13B/TNFRSF13B-Dependent Proliferation and Survival of Myeloma Cells.

Authors:  Lingzhang Meng; Qiang Tang; Jingjie Zhao; Zechen Wang; Liuzhi Wei; Qiuju Wei; Lianfei Yin; Shiguan Luo; Jian Song
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.